Procalcitonin guidance for reduction of antibiotic use in low-risk outpatients with community-acquired pneumonia

Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial

(2010) Lila Bouadma et al.   LANCET

Procalcitonin assay in systemic inflammation, infection, and sepsis: Clinical utility and limitations

(2009) Kenneth L. Becker et al.   CRITICAL CARE MEDICINE

Effect of Procalcitonin-Based Guidelines vs Standard Guidelines on Antibiotic Use in Lower Respiratory Tract Infections

(2009) Philipp Schuetz et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Procalcitonin-Guided Antibiotic Use vs a Standard Approach for Acute Respiratory Tract Infections in Primary Care

(2008) Matthias Briel et al.   ARCHIVES OF INTERNAL MEDICINE

Procalcitonin is a valuable prognostic marker in ARDS caused by community-acquired pneumonia

(2008) Jeng-Sen TSENG et al.   RESPIROLOGY

Use of Procalcitonin to Shorten Antibiotic Treatment Duration in Septic Patients

(2007) Vandack Nobre et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes

(2007) S. Kruger et al.   EUROPEAN RESPIRATORY JOURNAL